Cargando…
MeCP2 Promotes Gastric Cancer Progression Through Regulating FOXF1/Wnt5a/β-Catenin and MYOD1/Caspase-3 Signaling Pathways
Methyl-CpG binding protein 2 (MeCP2) has recently been characterized as an oncogene frequently amplified in several types of cancer. However, its precise role in gastric cancer (GC) and the molecular mechanism of MeCP2 regulation are still largely unknown. Here we report that MeCP2 is highly express...
Autores principales: | Zhao, Lingyu, Liu, Yingxun, Tong, Dongdong, Qin, Yannan, Yang, Juan, Xue, Meng, Du, Ning, Liu, Liying, Guo, Bo, Hou, Ni, Han, Jia, Liu, Siyuan, Liu, Na, Zhao, Xiaoge, Wang, Lumin, Chen, Yanke, Huang, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474507/ https://www.ncbi.nlm.nih.gov/pubmed/28131747 http://dx.doi.org/10.1016/j.ebiom.2017.01.021 |
Ejemplares similares
-
MeCP2 drives hepatocellular carcinoma progression via enforcing HOXD3 promoter methylation and expression through the HB‐EGF/EGFR pathway
por: Wang, Lumin, et al.
Publicado: (2021) -
MiR-22, regulated by MeCP2, suppresses gastric cancer cell proliferation by inducing a deficiency in endogenous S-adenosylmethionine
por: Tong, Dongdong, et al.
Publicado: (2020) -
MeCP2 confers 5-fluorouracil resistance in gastric cancer via upregulating the NOX4/PKM2 pathway
por: Qin, Yannan, et al.
Publicado: (2022) -
MeCP2 and Chromatin Compartmentalization
por: Schmidt, Annika, et al.
Publicado: (2020) -
MeCP2_e2 partially compensates for lack of MeCP2_e1: A male case of Rett syndrome
por: Takeguchi, Ryo, et al.
Publicado: (2019)